Larken Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LARKEN LABS, and what generic and branded alternatives to LARKEN LABS drugs are available?
LARKEN LABS has five approved drugs.
Drugs and US Patents for Larken Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Larken Labs | OFLOXACIN | ofloxacin | TABLET;ORAL | 076093-002 | Sep 2, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Larken Labs Inc | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | TABLET;ORAL | 204209-001 | Sep 30, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Larken Labs | OFLOXACIN | ofloxacin | TABLET;ORAL | 076093-001 | Sep 2, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.